Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UPDATE: Arhaus Q2 Adj. EPS $0.28 Beats $0.12 Estimate

Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.12 by 133.33 percent.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.12 by 133.33 percent.

Analyst Beefs Up Beam Therapeutics Price Target, Says ‘Reward Is Now Skewed To Upside’

By Vandana Singh

December 20, 2:51 PM

BMO Capital Markets has upgraded Beam Therapeutics Inc (NASDAQ:BEAM) from Market Perform to Outperform and raised the price target from $61 to…

BEAM

Rocky Brands Q4 Adj. EPS $1.86 Beats $0.95 Estimate, Sales $169.45M Beat $163.08M Estimate

By Bill Haddad

March 1, 5:34 PM

Rocky Brands (NASDAQ:RCKY) reported quarterly earnings of $1.86 per share which beat the analyst consensus estimate of $0.95 by 95.79 percent. This is a 31.91 percent increase over earnings of $1.41 per share from the

RCKY

FDA Clears Use Of Eli Lilly’s Insulin With Insulet’s Infusion Pumps

By Vandana Singh

August 16, 3:01 PM

The FDA has approved the use of Eli Lilly And Co’s (NYSE:LLY) Lyumjev (insulin lispro-aabc injection) 100 units/mL with Insulet Corporation’s (NASDAQ:PODD) insulin management…

LLY